Preventive effect of doxycycline sponge against bisphosphonate-related osteonecrosis of the jaws: an animal study

References

• Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg. 2003;61:1115–1117.
   PubMed Web of Science ®Google Scholar
• Russell RG, Watts NB, Ebetino FH, et al. Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int. 2008;19:733–759.
   PubMed Web of Science ®Google Scholar
• Sharma D, Ivanovski S, Slevin M, et al. Bisphosphonate-related osteonecrosis of jaw (BRONJ): diagnostic criteria and possible pathogenic mechanisms of an unexpected anti-angiogenic side effect. Vasc Cell. 2013;5:1.
   PubMed Web of Science ®Google Scholar
• La Ferla F, Paolicchi E, Crea F, et al. An aromatase polymorphism (g.132810C>T) predicts risk of bisphosphonate-related osteonecrosis of the jaw. Biomark Med. 2012;6:201–209.
   PubMed Web of Science ®Google Scholar
• Coleman R, Costa L, Saad F, et al. Consensus on the utility of bone markers in the malignant bone disease setting. Crit Rev Oncol Hematol. 2011;80:411–432.
   PubMed Web of Science ®Google Scholar
• Marx RE, Cillo JE Jr, Ulloa JJ. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg. 2007;65:2397–2410.
   PubMed Web of Science ®Google Scholar
• Hannon RA, Clowes JA, Eagleton AC, et al. Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorption. Bone. 2004;34:187–194.
   PubMed Web of Science ®Google Scholar
• Kim JW, Cha IH, Kim SJ, et al. Biomarkers for bisphosphonate-related osteonecrosis of the jaw. Clin Implant Dent Relat Res. 2016;18:281–291.
   PubMed Web of Science ®Google Scholar
• Khosla S, Burr D, Cauley J, et al. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2007;22:1479–1491.
   PubMed Web of Science ®Google Scholar
• López-Jornet P, Camacho-Alonso F, Martínez-Canovas A, et al. Perioperative antibiotic regimen in rats treated with pamidronate plus dexamethasone and subjected to dental extraction: a study of the changes in the jaws. J Oral Maxillofac Surg. 2011;69:2488–2493.
   PubMed Web of Science ®Google Scholar
• Abtahi J, Agholme F, Aspenberg P. Prevention of osteonecrosis of the jaw by mucoperiosteal coverage in a rat model. Int J Oral Maxillofac Surg. 2013;42:632–636.
   PubMed Web of Science ®Google Scholar
• Ruggiero SL, Dodson TB, Assael LA, et al. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws–2009 update. J Oral Maxillofac Surg. 2009;67:2–12.
   PubMed Web of Science ®Google Scholar
• Stoller NH, Johnson LR, Trapnell S, et al. The pharmacokinetic profile of a biodegradable controlled-release delivery system containing doxycycline compared to systemically delivered doxycycline in gingival crevicular fluid, saliva, and serum. J Periodontol. 1998;69:1085–1091. Erratum in: J Periodontol. 1999;70:238.
   PubMed Web of Science ®Google Scholar
• Senel FC, Kadioglu Duman M, Muci E, et al. Jaw bone changes in rats after treatment with zoledronate and pamidronate. Oral Surg Oral Med Oral Pathol Oral Radiol. 2010;109:385–391.
   Web of Science ®Google Scholar
• Dayisoylu EH, Şenel FÇ, Üngör C, et al. The effects of adjunctive parathyroid hormone injection on bisphosphonate-related osteonecrosis of the jaws: an animal study. Int J Oral Maxillofac Surg. 2013;42:1475–1480.
   PubMed Web of Science ®Google Scholar
• Dayisoylu EH, Üngör C, Tosun E, et al. Does an alkaline environment prevent the development of bisphosphonate-related osteonecrosis of the jaw? An experimental study in rats. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117:329–334.
   PubMed Web of Science ®Google Scholar
• Ersan N, van Ruijven LJ, Bronckers AL, et al. Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model. Dentomaxillofac Radiol. 2014;43:20130144.
   PubMed Web of Science ®Google Scholar
• Barba-Recreo P, Del Castillo Pardo de Vera JL, García-Arranz M,et al. Zoledronic acid-related osteonecrosis of the jaws. Experimental model with dental extractions in rats. J Craniomaxillofac Surg. 2014;42:744–750.
   PubMed Web of Science ®Google Scholar
• Sarkarat F, Kalantar Motamedi MH, Jahanbani J, et al. Platelet-rich plasma in treatment of zoledronic acid-induced bisphosphonate-related osteonecrosis of the jaws. Trauma Mon. 2014;19:e17196.
   PubMedGoogle Scholar
• Ruggiero SL, Dodson TB, Fantasia J, et al. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw–2014 update. J Oral Maxillofac Surg. 2014;72:1938–1956.
   PubMed Web of Science ®Google Scholar
• Kunchur R, Need A, Hughes T, et al. Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws. J Oral Maxillofac Surg. 2009;67:1167–1173.
   PubMed Web of Science ®Google Scholar
• Kwon YD, Kim DY, Ohe JY, et al. Correlation between serum C-terminal cross-linking telopeptide of type I collagen and staging of oral bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg. 2009;67:2644–2648.
   PubMed Web of Science ®Google Scholar
• Glover SJ, Garnero P, Naylor K, et al. Establishing a reference range for bone turnover markers in young, healthy women. Bone. 2008;42:623–630.
   PubMed Web of Science ®Google Scholar
• Kim JW, Kong KA, Kim SJ, et al. Prospective biomarker evaluation in patients with osteonecrosis of the jaw who received bisphosphonates. Bone. 2013;57:201–205.
   PubMed Web of Science ®Google Scholar
• Rissanen JP, Suominen MI, Peng Z, et al. Secreted tartrate-resistant acid phosphatase 5b is a marker of osteoclast number in human osteoclast cultures and the rat ovariectomy model. Calcif Tissue Int. 2008;82:108–115.
   PubMed Web of Science ®Google Scholar
• Kuroshima S, Go VA, Yamashita J. Increased numbers of nonattached osteoclasts after long-term zoledronic acid therapy in mice. Endocrinology. 2012;153:17–28.
   PubMed Web of Science ®Google Scholar
• Çankaya M, Cizmeci Şenel F, Kadioglu Duman M, et al. The effects of chronic zoledronate usage on the jaw and long bones evaluated using RANKL and osteoprotegerin levels in an animal model. Int J Oral Maxillofac Surg. 2013;42:1134–1139.
   PubMed Web of Science ®Google Scholar
• Kollet O, Dar A, Shivtiel S, et al. Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat Med. 2006;12:657–664.
   PubMed Web of Science ®Google Scholar
• Rogers MJ. From molds and macrophages to mevalonate: a decade of progress in understanding the molecular mode of action of bisphosphonates. Calcif Tissue Int. 2004;75:451–461.
   PubMed Web of Science ®Google Scholar
• Weinstein RS, Roberson PK, Manolagas SC. Giant osteoclast formation and long-term oral bisphosphonate therapy. N Engl J Med. 2009;360:53–62.
   PubMed Web of Science ®Google Scholar
• Sedghizadeh PP, Kumar SK, Gorur A, et al. Identification of microbial biofilms in osteonecrosis of the jaws secondary to bisphosphonate therapy. J Oral Maxillofac Surg. 2008;66:767–775.
   PubMed Web of Science ®Google Scholar
• Tsurushima H, Kokuryo S, Sakaguchi O, et al. Bacterial promotion of bisphosphonate-induced osteonecrosis in Wistar rats. Int J Oral Maxillofac Surg. 2013;42:1481–1487.
   PubMed Web of Science ®Google Scholar
• Kaplan I, Anavi K, Anavi Y, et al. The clinical spectrum of Actinomyces-associated lesions of the oral mucosa and jaw bones: correlations with histomorphometric analysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108:738–746.
   PubMed Web of Science ®Google Scholar
• Hinson AM, Smith CW, Siegel ER, et al. Is bisphosphonate-related osteonecrosis of the jaw an infection? A histological and microbiological ten-year summary. Int J Dent. 2014;2014:452737.
   PubMedGoogle Scholar
• Pushalkar S, Li X, Kurago Z, et al. Oral microbiota and host innate immune response in bisphosphonate-related osteonecrosis of the jaw. Int J Oral Sci. 2014;6:219–226.
   PubMed Web of Science ®Google Scholar
• Otto S, Hafner S, Mast G, et al. Bisphosphonate-related osteonecrosis of the jaw: is pH the missing part in the pathogenesis puzzle? J Oral Maxillofac Surg. 2010;68:1158–1161.
   PubMed Web of Science ®Google Scholar
• Kimachi K, Kajiya H, Nakayama S, et al. Zoledronic acid inhibits RANK expression and migration of osteoclast precursors during osteoclastogenesis. Naunyn Schmiedebergs Arch Pharmacol. 2011;383:297–308.
   PubMed Web of Science ®Google Scholar
• Ji X, Pushalkar S, Li Y, et al. Antibiotic effects on bacterial profile in osteonecrosis of the jaw. Oral Dis. 2012;18:85–95.
   PubMed Web of Science ®Google Scholar
• Walker CB, Pappas JD, Tyler KZ, et al. Antibiotic susceptibilities of periodontal bacteria: in vitro susceptibilities to eight antimicrobial agents. J Periodontol. 1985;56:67–74.
   PubMedGoogle Scholar